Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Psychiatry
•
Behavioral Neurology & Neuropsychiatry
Is there sufficient evidence yet to support the use of lithium supplementation or prescription in the management of neurodegenerative diseases?
Would you consider it in a patient with strong familial risk of early onset NDD?
Related Questions
How do stroke-risk considerations affect your use of atypical antipsychotics for patients with dementia?
What is your approach to Tardive Dyskinesia when VMAT2 inhibitors are ineffective or unaffordable?
What is your approach to determining eligibility for hospice in persons with Alzheimer's disease?
How do you manage problematic disinhibited behaviors in patients with neurocognitive disorders?
What are the limits and standalone value of volumetric MRI for the preclinical evaluation of dementia?
What is your approach to the management of transfusion reactions with lecanemab, both in the immediate setting and with respect to the prevention of reactions with future infusions?
How do you treat agitation in progressive supranuclear palsy?
When is it useful to test for multiple amyloid-related biomarkers for patients underoing work-up for cognitive impairment?
What is your preferred first-line agent to treat anxiety in patients with Parkinson's disease?
What are your go-to options for managing ICU delirium in patients with contraindications to antipsychotics?